Life Science Company News

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects. 

Read more ››
By: GlobeNewswire - 17 Apr 2024

AAMI Releases Guidance on Dilator, Ultrasound DeSterilization

Read more ››
By: GlobeNewswire - 17 Apr 2024

Ipsen publishes its 2023 Universal Registration Document

Read more ››
By: GlobeNewswire - 17 Apr 2024

River Oaks Treatment Center is Setting the Standard for Clinical Excellence in Florida with Four Board-Certified Addiction Medicine Physicians

Read more ››
By: GlobeNewswire - 17 Apr 2024

Hospice Choices: VITAS® Healthcare Opens in Alabama, Expands in Florida Panhandle

Read more ››
By: GlobeNewswire - 17 Apr 2024

Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Heatwaves Hit Harder for People with Disabilities: A Pusan National University Study Finds Increased Emergency Visits

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Datasea Secures Combined $15 Million with its Second Sales Contract for Acoustic Products

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Asieris Pharmaceuticals Unveils 2023 Annual Report, Core Product APL-1702 Succeeds in Global Phase III Clinical Trials, APL-1706 obtains NDA acceptance domestically, Specialty Commercial Team Generates Sustained Revenue Streams

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Canaan Adds Accomplished Executive and Scientist, Uwe Schoenbeck, Ph.D., Along with New Capital, to Bolster its Biopharma Investment Efforts

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

International Study Compares Self-Expanding and Balloon-Expandable Transcatheter Aortic-Valve Replacement in Patients with Small Aortic Annulus

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Syra Health and Maricopa County Partner for Third Public Health Training

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Halia Therapeutics to Present at Asia BIO 2024

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Sanochemia: New contrast agent aims to detect the smallest lymphatic metastases in prostate cancer

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Tel Aviv Sourasky Medical Center (TASMC) partners with the AI innovator NeuroBrave to bring Generative AI into the field of BCI (Brain-Computer Interfaces)

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate